They reported that an overexpression of periplakin reduced cancer cell migration and invasion, induced a G1/G0 cell cycle arrest, and inhibited colon cancer cell proliferation by suppressing the activation of ERK1/2 and the expression of proliferating cell nuclear antigen (PCNA). Here, PCNA is linked to colonic neoplasm.